Prof. Paul Lorigan is a distinguished Professor of Medical Oncology at the University of Manchester and an Honorary Consultant Medical Oncologist at the Christie NHS Foundation Trust. He is internationally renowned for his pioneering clinical research into new treatments for melanoma.

Prof. Lorigan graduated from Trinity College, University of Dublin in 1986, where he completed his specialist training in haematology and oncology. He began his esteemed career as an Honorary Consultant and Senior Lecturer in Medical Oncology at The University of Sheffield and Weston Park Hospital in 1996. In 2002, he joined The Christie and the University of Manchester as a Consultant and Senior Lecturer.

With a career spanning over two decades, Prof. Lorigan has made significant contributions to the field of oncology. He is a principal investigator for numerous international clinical trials and has held prestigious positions such as Chair of the UK charity Melanoma Focus and the EORTC Melanoma Group Advanced Disease Subgroup. His extensive research has been published in over 200 papers, chapters, and reviews, and he is a regular speaker at international medical conferences.

Prof. Lorigan's areas of expertise include chemotherapy, immunotherapy, and circulating tumour cells. He specialises in the treatment of melanoma and skin cancer, offering advanced and innovative care to his patients. His dedication to improving patient outcomes through research and clinical practice has earned him a reputation as a leading expert in his field.

Since his appointment, Prof. Lorigan has been committed to advancing the understanding and treatment of melanoma and skin cancer, making significant strides in the development of new therapies. His work continues to inspire and influence the global medical community.